NUTX vs MD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 29, 2026
NUTX
MD
Investment Advisor Scores
MD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NUTX | MD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 9.2937 | Tie |
| PEG Ratio | 0 | 0.2433 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -13.6% | 4.0% | MD |
| Earnings Growth | 95.9% | 6.5% | NUTX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 33.6/100 | 61.8/100 | MD |
| Profit Margin | 21.2% | 9.0% | NUTX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | BUY | MD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NUTX
MarkupPrice above SMA50, rising 50-day trend (7.8% over 20 days), RSI 61
MD
NeutralMixed signals - no dominant trend phase, RSI 45
Fundamentals Snapshot
| Metric | NUTX | MD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.8 | 10.6 |
| Trailing P/E | 8.2 | 12.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.0% |
| Gross Margin | 0.5% | 0.3% |
| Operating Margin | 0.6% | 0.1% |
| EPS | 25.88 | 2.09 |
| Dividend Yield | — | — |